The Cooper Companies, Inc. (COO)

The Base case envisions steady compounding driven by ongoing conversion to premium daily disposable contact lenses, defensive gross margins, and gradual deleveraging. Performance tracks toward Fair value of $78.48, supported by stable replacement demand across optometry networks. The thesis would be challenged if European revenue decelerates or if surgical segment margins fail to recover.

• Core vision care revenue expands at a moderate pace aligned with demographic correction needs
• Consolidated operating margins remain defensive within historical ranges
• Surplus cash flow is directed toward continuous debt paydown